Clinical Trials Logo
  1. Home
  2. Pulmonary Artery Hypertension
  3. NCT00502398
  4. Details
NCT00502398 Clinical Trial

Is There Intravascular Hemolysis in Patients With Pulmonary Hypertension?

Pulmonary Artery Hypertension Clinical Trial

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT00502398
Other study ID # RMC074490CTIL
Secondary ID
Status Recruiting
Phase N/A
First received July 15, 2007
Last updated October 14, 2007
Start date September 2007

Study information
Verified date October 2007
Source Rabin Medical Center
Contact Ben Fox, MRCP
Phone +972 3 937 7221
Email foxb@clalit.org.il
Is FDA regulated No
Health authority Israel: Clalit Health Services
Study type Observational

Clinical Trial Summary

Patients with hemolytic disorders (e.g. sickle cell anemia or thalassemia) are known to develop pulmonary hypertension. Hemolysis is where red blood cells are destroyed and their contents released into the circulation. It is thought that these red-cell contents cause constriction and thrombosis of the blood vessels in the lungs. Conversely, it is possible that patients with pulmonary hypertension have hemolysis.

In this study we will be drawing blood from a range of patients and normal controls for a panel of blood tests related to hemolysis.

Recruitment information / eligibility
Status Recruiting
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

One of the following four conditions :

- Pulmonary artery hypertension

- Obstructive sleep apnea with pulmonary hypertension

- Lung transplant candidates without pulmonary hypertension

- Normal Controls

Exclusion Criteria:

- Known hemolytic disorder

- Recent blood loss (<3 months)

- Recent blood transfusion (<3 months)

- Liver disease

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

Intervention

Procedure:
• Blood test

Locations
Country Name City State
Israel Pulmonary Institute, Rabin Medical Center (Beilinson campus) Petach Tikva

Sponsors (1)
Lead Sponsor Collaborator
Rabin Medical Center

Country where clinical trial is conducted

Israel, 

See also
  Status Clinical Trial Phase
Completed NCT05056532 - Evaluation of Respiratory Muscle in Patient With Pulmonary Arterial Hypertension
Active, not recruiting NCT06003244 - High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT) N/A
Active, not recruiting NCT06072417 - HA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea Level) N/A
Recruiting NCT02966665 - : Vascular Function in Health and Disease Phase 1
Completed NCT04456998 - GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) Phase 2
Not yet recruiting NCT06035861 - Endothelial Cell Activation and Total Pulmonary Resistance in PAH N/A
Recruiting NCT03138863 - Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO) N/A
Recruiting NCT02102672 - Trimetazidine in Pulmonary Artery Hypertension Phase 2
Withdrawn NCT06122922 - Xenon MRI in Stable Pulmonary Hypertension (Jupiter AUGEAN) Phase 2
Recruiting NCT03195543 - Assessment of Blood Coagulation Disorders in Patients With Pulmonary Hypertension
Completed NCT04337671 - Impact of Aerobic Training on Sleep Quality and Aerobic Fitness in Male Patients With Pulmonary Artery Hypertension N/A
Completed NCT03198910 - Retrospective Data Analysis of Data From the Zurich PH Registry
Completed NCT03979482 - Skeletal Muscle Mitochondrial Abnormalities and the Metabolic Syndrome in PAH
Active, not recruiting NCT06084559 - HA Residents With PVD, Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) With and Without Supplemental Oxygen Therapy (SOT) N/A
Active, not recruiting NCT05996302 - HA Residents With PVD, 6MWD Assessed at HA (2840m) vs LA (Sea Level) N/A
Withdrawn NCT02684786 - A Study of Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary Hypertension Phase 1
Not yet recruiting NCT06258850 - REstoration of VItamin D in Pulmonary Arterial Hypertension Phase 4
Completed NCT04094272 - Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection
Active, not recruiting NCT01763112 - Training With Whole Body Vibration Device in Patients With PAH N/A
Completed NCT01581086 - Vascular Subphenotypes of Lung Disease in HIV & COPD N/A